Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Return on Sales (2020 - 2023)

Historic Return on Sales for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to 1.19%.

  • Candel Therapeutics' Return on Sales rose 2528400.0% to 1.19% in Q4 2023 from the same period last year, while for Dec 2023 it was 12.99%, marking a year-over-year increase of 2709700.0%. This contributed to the annual value of 14.45% for FY2024, which is 14600.0% down from last year.
  • As of Q4 2023, Candel Therapeutics' Return on Sales stood at 1.19%, which was up 2528400.0% from 13.49% recorded in Q3 2023.
  • Over the past 5 years, Candel Therapeutics' Return on Sales peaked at 15.65% during Q1 2023, and registered a low of 295.52% during Q1 2022.
  • Over the past 4 years, Candel Therapeutics' median Return on Sales value was 171.48% (recorded in 2021), while the average stood at 152.61%.
  • In the last 5 years, Candel Therapeutics' Return on Sales plummeted by -1721000bps in 2021 and then soared by 3111700bps in 2023.
  • Quarter analysis of 4 years shows Candel Therapeutics' Return on Sales stood at 196.0% in 2020, then dropped by -28bps to 250.03% in 2021, then decreased by -2bps to 254.03% in 2022, then soared by 100bps to 1.19% in 2023.
  • Its Return on Sales was 1.19% in Q4 2023, compared to 13.49% in Q3 2023 and 15.17% in Q2 2023.